Want to see BBOT full AI Analyst Report?
BridgeBio Oncology Therapeutics (BBOT) Hedge Fund Trading Activity
Trend: ▼ Hedge Funds Decreased Holdings by 289.5K Shares Last Quarter
Hedge Fund Holdings in BBOT
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| Hedge Fund Manager | Star Ranking | Firm | Activity | Holding Change | Value Reported | % of Portfolio | Follow |
|---|---|---|---|---|---|---|---|
| Not Ranked | Added | 3.15% | $16,413,785 | <0.01% | |||
| Deerfield Management Company, LP | Not Changed | 0.00% | $37,227,099 | 0.39% | |||
| Omega Fund Management, LLC | Not Changed | 0.00% | $25,067,217 | 13.50% | |||
| Aisling Capital Management LP | Not Changed | 0.00% | $7,757,297 | 1.64% | |||
| Moore Capital Management LP | Not Changed | 0.00% | $762,000 | 0.01% | |||
| Royce & Associates LLC | Reduced | -39.52% | $2,933,250 | 0.02% | |||
| Woodline Partners LP | Sold Out | -100.00% | $0 | 0.00% |
FAQ
Which hedge funds hold BridgeBio Oncology Therapeutics?
The hedge funds that hold the most shares in BridgeBio Oncology Therapeutics are BlackRock, Inc., Chuck Royce and Otello Stampacchia.
Are hedge funds buying or selling BBOT?
In the last quarter hedge funds have Decreased their holdings in BridgeBio Oncology Therapeutics by 289.5K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in BridgeBio Oncology Therapeutics stock?
Warren Buffet currently does not own shares in BridgeBio Oncology Therapeutics.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here